Latest Versant Venture Management, LLC Stock Portfolio
$388Million
Equity Portfolio Value
Last Reported on: 08 Feb, 2024
About Versant Venture Management, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $388.8 Millions as of 31 Dec, 2023.
The top stock holdings of Versant Venture Management, LLC are , CRSP, RPTX. The fund has invested 82.5% of it's portfolio in RAYZEBIO, INC. and 8% of portfolio in CRISPR THERAPEUTICS AG.
The fund managers got completely rid off MINERVA SURGICAL INC. (UTRS) stocks.
The top stock holdings of Versant Venture Management, LLC are , CRSP, RPTX. The fund has invested 82.5% of it's portfolio in RAYZEBIO, INC. and 8% of portfolio in CRISPR THERAPEUTICS AG.
The fund managers got completely rid off MINERVA SURGICAL INC. (UTRS) stocks.
New Buys
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| MINERVA SURGICAL INC. | -275,320 |
Versant Venture Management, LLC got rid off the above stocks
Current Stock Holdings of Versant Venture Management, LLC
Last Reported on: 08 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ADVM | ADVERUM BIOTECHNOLOGIES, INC. | 0.98 | 5,068,230 | 3,815,370 | UNCHANGED | 0.00 | |
| ALGS | ALIGOS THERAPEUTICS, INC. | 0.40 | 2,320,380 | 1,540,730 | UNCHANGED | 0.00 | |
| CRSP | CRISPR THERAPEUTICS AG | 8.03 | 498,558 | 31,209,700 | UNCHANGED | 0.00 | |
| GRTS | GRITSTONE BIO, INC. | 1.87 | 3,561,150 | 7,264,750 | UNCHANGED | 0.00 | |
| PASG | PASSAGE BIO, INC. | 1.29 | 4,959,770 | 5,009,370 | UNCHANGED | 0.00 | |
| RPTX | REPARE THERAPEUTICS, INC. | 4.97 | 2,646,660 | 19,320,600 | UNCHANGED | 0.00 | |
| UTRS | MINERVA SURGICAL INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RAYZEBIO, INC. | 82.47 | 5,158,160 | 320,683,000 | UNCHANGED | 0.00 |